AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Prostate Cancer Foundation
Grant: 17CHAL17
HHS | National Institutes of Health
Grant: R01 CA231349-01A1
HHS | National Institutes of Health
Grant: R35 GM130119
UT | University of Texas MD Anderson Cancer Center
Grant: Prostate Cancer Moon Shot
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5P30DK056338-18
Texas Medical Center Digestive Diseases Center
National Institutes of Health
Grant: 1R01CA231349-01A1
Developing Novel Therapeutic Approaches Targeting Macrophages in GBM
National Institutes of Health
Grant: 3R35GM130119-07S1
High-content microscopy platform for multiplex perturbation/multiplex readout studies
FWCI
1.04
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals